Assignment of risk points to prognostic factors in the additive risk model for patients with intermediate-risk cytogenetics
| Parameter/subgroup . | Score, points . |
|---|---|
| CD34 expression | |
| Less than or equal to 10% | 0 |
| More than 10% | 2 |
| WBC | |
| Less than or equal to 20/μL | 0 |
| More than 20/μL | 2 |
| Age, y | |
| Less than or equal to 65 | 0 |
| More than 65 | 3 |
| LDH | |
| Less than or equal to 700 U/L | 0 |
| More than 700 U/L | 4 |
| NPM1 status | |
| Wild-type | 0 |
| Mutated | −2 |
| Parameter/subgroup . | Score, points . |
|---|---|
| CD34 expression | |
| Less than or equal to 10% | 0 |
| More than 10% | 2 |
| WBC | |
| Less than or equal to 20/μL | 0 |
| More than 20/μL | 2 |
| Age, y | |
| Less than or equal to 65 | 0 |
| More than 65 | 3 |
| LDH | |
| Less than or equal to 700 U/L | 0 |
| More than 700 U/L | 4 |
| NPM1 status | |
| Wild-type | 0 |
| Mutated | −2 |